FULGENT GENETICS, INC. Deferred Income Tax Expense (Benefit)
FULGENT GENETICS, INC. (FLGT) reported Deferred Income Tax Expense (Benefit) of -$1.21 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Operating Activities
us-gaap:DeferredIncomeTaxExpenseBenefit · last filed 2026-07-30
- FULGENT GENETICS, INC. deferred income tax expense (benefit) for the quarter ending 2026-06-30 was -$90.00K.
- FULGENT GENETICS, INC. deferred income tax expense (benefit) for the quarter ending 2026-03-31 was -$1.12M.
- FULGENT GENETICS, INC. deferred income tax expense (benefit) for the quarter ending 2025-12-31 was -$104.00K.
- FULGENT GENETICS, INC. deferred income tax expense (benefit) for the quarter ending 2025-09-30 was -$864.00K.
- FULGENT GENETICS, INC. deferred income tax expense (benefit) for fiscal 2025 was -$1.21M.
- FULGENT GENETICS, INC. deferred income tax expense (benefit) for fiscal 2024 was -$3.74M, a 132.58% decline from fiscal 2023.
- FULGENT GENETICS, INC. deferred income tax expense (benefit) for fiscal 2023 was $11.47M.
- FULGENT GENETICS, INC. deferred income tax expense (benefit) for fiscal 2022 was -$8.28M.
| Period end | Deferred Income Tax Expense (Benefit) 3 month | Deferred Income Tax Expense (Benefit) 6 month | Deferred Income Tax Expense (Benefit) 9 month | Deferred Income Tax Expense (Benefit) 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$90.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | -$1.21M 10-Q · filed 2026-07-30 | -$1.31M derived: sum of 3 quarters · filed 2026-07-30 | -$2.18M derived: sum of 4 quarters · filed 2026-07-30 |
| 2026-03-31 | -$1.12M 10-Q · filed 2026-05-01 | -$1.22M derived: sum of 2 quarters · filed 2026-05-01 | -$2.09M derived: sum of 3 quarters · filed 2026-05-01 | -$2.20M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-12-31 | -$104.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$968.00K derived: sum of 2 quarters · filed 2026-02-27 | -$1.08M derived: sum of 3 quarters · filed 2026-07-30 | -$1.21M 10-K · filed 2026-02-27 |
| 2025-09-30 | -$864.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | -$977.00K derived: sum of 2 quarters · filed 2026-07-30 | -$1.11M 10-Q · filed 2025-11-07 | -$1.47M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-06-30 | -$113.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | -$246.00K 10-Q · filed 2026-07-30 | -$610.00K derived: sum of 3 quarters · filed 2026-07-30 | -$2.97M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-03-31 | -$133.00K 10-Q · filed 2026-05-01 | -$497.00K derived: sum of 2 quarters · filed 2026-05-01 | -$2.85M derived: sum of 3 quarters · filed 2026-05-01 | -$3.31M derived: sum of 4 quarters · filed 2026-05-01 |
| 2024-12-31 | -$364.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$2.72M derived: sum of 2 quarters · filed 2026-02-27 | -$3.18M derived: sum of 3 quarters · filed 2026-02-27 | -$3.74M 10-K · filed 2026-02-27 |
| 2024-09-30 | -$2.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | -$2.81M derived: sum of 2 quarters · filed 2025-11-07 | -$3.37M 10-Q · filed 2025-11-07 | -$2.87M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | -$457.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-01 | -$1.01M 10-Q · filed 2025-08-01 | -$512.00K derived: sum of 3 quarters · filed 2026-02-27 | $18.87M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | -$557.00K 10-Q · filed 2025-05-02 | -$55.00K derived: sum of 2 quarters · filed 2026-02-27 | $19.33M derived: sum of 3 quarters · filed 2026-02-27 | $16.11M derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | $502.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $19.88M derived: sum of 2 quarters · filed 2026-02-27 | $16.67M derived: sum of 3 quarters · filed 2026-02-27 | $11.47M 10-K · filed 2026-02-27 |
| 2023-09-30 | $19.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $16.16M derived: sum of 2 quarters · filed 2024-11-08 | $10.96M 10-Q · filed 2024-11-08 | $7.62M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | -$3.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02 | -$8.42M 10-Q · filed 2024-08-02 | -$11.76M derived: sum of 3 quarters · filed 2025-02-28 | -$9.06M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | -$5.20M 10-Q · filed 2024-05-03 | -$8.55M derived: sum of 2 quarters · filed 2025-02-28 | -$5.84M derived: sum of 3 quarters · filed 2025-02-28 | -$7.98M derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | -$3.35M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | -$641.00K derived: sum of 2 quarters · filed 2025-02-28 | -$2.78M derived: sum of 3 quarters · filed 2025-02-28 | -$8.28M 10-K · filed 2025-02-28 |
| 2022-09-30 | $2.71M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | $563.00K derived: sum of 2 quarters · filed 2023-11-03 | -$4.93M 10-Q · filed 2023-11-03 | -$6.55M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | -$2.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | -$7.64M 10-Q · filed 2023-08-04 | -$9.25M derived: sum of 3 quarters · filed 2024-02-28 | -$12.77M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | -$5.50M 10-Q · filed 2023-05-05 | -$7.11M derived: sum of 2 quarters · filed 2024-02-28 | -$10.63M derived: sum of 3 quarters · filed 2024-02-28 | -$12.90M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | -$1.61M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | -$5.13M derived: sum of 2 quarters · filed 2024-02-28 | -$7.40M derived: sum of 3 quarters · filed 2024-02-28 | -$8.19M 10-K · filed 2024-02-28 |
| 2021-09-30 | -$3.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | -$5.79M derived: sum of 2 quarters · filed 2022-11-07 | -$6.57M 10-Q · filed 2022-11-07 | -$7.27M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | -$2.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$3.06M 10-Q · filed 2022-08-04 | -$3.75M derived: sum of 3 quarters · filed 2023-02-28 | |
| 2021-03-31 | -$786.00K 10-Q · filed 2022-05-05 | -$1.48M derived: sum of 2 quarters · filed 2023-02-28 | ||
| 2020-12-31 | -$692.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$1.77M 10-K · filed 2023-02-28 | ||
| 2020-09-30 | -$1.08M 10-Q · filed 2021-11-09 | |||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | -$21.00K 10-K · filed 2022-02-28 | ||
| 2019-09-30 | -$21.00K 10-Q · filed 2020-11-09 | |||
| 2018-12-31 | $923.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | $571.00K derived: sum of 2 quarters · filed 2020-03-13 | $470.00K derived: sum of 3 quarters · filed 2020-03-13 | $36.00K 10-K · filed 2020-03-13 |
| 2018-09-30 | -$352.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | -$453.00K derived: sum of 2 quarters · filed 2019-11-08 | -$887.00K 10-Q · filed 2019-11-08 | |
| 2018-06-30 | -$101.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-12 | -$535.00K 10-Q · filed 2019-08-12 | ||
| 2018-03-31 | -$434.00K 10-Q · filed 2019-05-10 | |||
| 2017-12-31 | -$336.00K 10-K · filed 2019-03-22 | |||
| 2016-12-31 | -$171.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-20 | $246.00K 10-K · filed 2018-03-20 | ||
| 2016-09-30 | $417.00K 10-Q · filed 2017-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B |